These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 15760423

  • 1. Quinolones in 2005: an update.
    Van Bambeke F, Michot JM, Van Eldere J, Tulkens PM.
    Clin Microbiol Infect; 2005 Apr; 11(4):256-80. PubMed ID: 15760423
    [Abstract] [Full Text] [Related]

  • 2. Selection of quinolone resistance in Streptococcus pneumoniae exposed in vitro to subinhibitory drug concentrations.
    Avrain L, Garvey M, Mesaros N, Glupczynski Y, Mingeot-Leclercq MP, Piddock LJ, Tulkens PM, Vanhoof R, Van Bambeke F.
    J Antimicrob Chemother; 2007 Nov; 60(5):965-72. PubMed ID: 17693451
    [Abstract] [Full Text] [Related]

  • 3. Pharmacodynamics: relation to antimicrobial resistance.
    Rybak MJ.
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S38-45; discussion S64-73. PubMed ID: 16813981
    [Abstract] [Full Text] [Related]

  • 4. Quinolones: clinical use and formulary considerations.
    Cunha BA.
    Adv Ther; 1998 Jun; 15(5):277-87. PubMed ID: 10345149
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chemometric methodologies in a quantitative structure-activity relationship study: the antibacterial activity of 6-aminoquinolones.
    Cecchetti V, Filipponi E, Fravolini A, Tabarrini O, Bonelli D, Clementi M, Cruciani G, Clementi S.
    J Med Chem; 1997 May 23; 40(11):1698-706. PubMed ID: 9171879
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The quinolones: past, present, and future.
    Andriole VT.
    Clin Infect Dis; 2005 Jul 15; 41 Suppl 2():S113-9. PubMed ID: 15942877
    [Abstract] [Full Text] [Related]

  • 13. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology].
    Derevianko II, Lopatkin NA, Khodyreva LA, Kondrat'eva EM.
    Urol Nefrol (Mosk); 1998 Jul 15; (5):14-8. PubMed ID: 9820038
    [No Abstract] [Full Text] [Related]

  • 14. [The new quinolones].
    Lontie M.
    J Pharm Belg; 1989 Jul 15; 44(4):292-301. PubMed ID: 2691640
    [Abstract] [Full Text] [Related]

  • 15. Susceptibility and bactericidal activity of 8 oral quinolones against conventional-fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates.
    Yokota S, Ohkoshi Y, Fujii N.
    Diagn Microbiol Infect Dis; 2009 Sep 15; 65(1):76-80. PubMed ID: 19679241
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antibiotic consumption and generation of resistance in Streptococcus pneumoniae: the paradoxical impact of quinolones in a complex selective landscape.
    García-Rey C, Martín-Herrero JE, Baquero F.
    Clin Microbiol Infect; 2006 May 15; 12 Suppl 3():55-66. PubMed ID: 16669929
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Quinolones for brucellosis: treating old diseases with new drugs.
    Pappas G, Christou L, Akritidis N, Tsianos EV.
    Clin Microbiol Infect; 2006 Sep 15; 12(9):823-5. PubMed ID: 16882286
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.